Abstract
The initial public offering (IPO) is an important stage in the life cycle of research-based firms. The purpose of this article is to examine the influence of gender diversity in top management teams (TMTs) on the success of the IPO of research-based firms. We also explore how critical indicators of innovation capabilities for those types of firms can mediate the gender effect. To test a set of hypotheses, we carried out a longitudinal study of a sample of dedicated biotechnology firms that went public in the United States. Results suggest there is a negative and significant relationship between gender diversity in executive management and IPO success in the specific context of the biotechnology industry. However, the effect of innovation capabilities reduces and causes no significant influence of such type of demographic diversity in TMTs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
